What I am asking you is, if you don’t act, 40,000 people a year could die? Is this acceptable to you?” the senator asked.

Senators grilled Novo Nordisk CEO Lars Jorgensen at a hearing on Tuesday about the cost of diabetes drug Ozempic and weight loss medication Wegovy, both of which are often prohibitively expensive in the United States despite their life-saving potential.

Senators grilled Novo Nordisk CEO Lars Jorgensen Tuesday at a hearing over the costs of Ozempic, Wegovy and similar weight loss drugs. The drugs have risen in popularity for diabetic patients and others looking to combat obesity since they were approved,